Jeffrey Scott Leighton
CIK: 0002132408
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMR
Imricor Medical Systems, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Leighton Jeffrey Scott
Leighton Jeffrey Scott (SEC CIK 0002132408) files insider reports with the SEC as Director of Imricor Medical Systems, Inc. (IMR).
Signal8 holds 1 ownership filing by Leighton Jeffrey Scott, a Form 3, filed on May 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Leighton Jeffrey Scott's filings is in BURNSVILLE, MN.
Other insiders filing for Imricor Medical Systems, Inc. (IMR)
- Messal Anita Marie Quamme, Director
- Wedan Steven Robert, President and CEO
- Gut Jonathon Thomas, VP of Finance and CFO
- Denti Aldo Mariano Roberto, Director
- Tibbles Mark Alden, Director
- McGregor Peter James, Director